Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Licenses Rosetta s Gene Expression-Analysis Software

NEW YORK, Oct. 3 (GenomeWeb News) - Agendia has licensed Rosetta's Resolver software and the two companies will collaborate to offer diagnostics tools for gene-expression analysis, the firms said today.


Rosetta and Agendia will "enable interoperability between the Resolver system and Agendia's clinical and gene expression database" to support Agendia's research and development of diagnostic products and services, Yelena Shevelenko, vice president and general manager of Rosetta, said in a statement.


Financial terms of the deal were not disclosed.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.